FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

15847911000001109: Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1874061000001117 Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1874071000001110 Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml Is a Nystatin 100,000units/ml oral suspension 30 ml true Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml Has AMP Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml Has specific active ingredient Nystatin true Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Nystatin 100,000units/ml oral suspension (Kent Pharma (UK) Ltd) 30 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start